These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10208310)

  • 1. Suppressive effect of pentoxifylline on natural killer cell activity; experimental and clinical studies.
    Nagy Z; Sipka R; Ocsovszki I; Balogh A; Mándi Y
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):228-34. PubMed ID: 10208310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro and clinical effect of pentoxifylline on natural killer cell activity].
    Nagy Z; Sipka R; Ocsovszki I; Balogh A; Mándi Y
    Orv Hetil; 1998 Oct; 139(41):2441-5. PubMed ID: 9805458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of pentoxifylline on natural killer cell activity.
    Reed WR; DeGowin RL
    J Lab Clin Med; 1992 Jun; 119(6):763-71. PubMed ID: 1593221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell mediated cytotoxicity against VERO target cells; the suppressive effect of pentoxifylline.
    Nagy Z; Mándi Y
    Immunol Lett; 1998 Sep; 63(2):121-3. PubMed ID: 9761374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline therapy in HIV seropositive subjects with elevated TNF.
    Kruse A; Rieneck K; Kappel M; Orholm M; Bruunsgaard H; Ullum H; Skinhøj P; Pedersen BK
    Immunopharmacology; 1995 Nov; 31(1):85-91. PubMed ID: 8655293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pentoxifylline].
    Paradowski PT; Zeman K
    Postepy Hig Med Dosw; 1995; 49(2):201-20. PubMed ID: 8657627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes.
    Neuner P; Klosner G; Pourmojib M; Knobler R; Schwarz T
    Immunology; 1997 Mar; 90(3):435-9. PubMed ID: 9155652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline inhibits T-cell adherence to keratinocytes.
    Bruynzeel I; van der Raaij LM; Stoof TJ; Willemze R
    J Invest Dermatol; 1995 Jun; 104(6):1004-7. PubMed ID: 7539468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules.
    Noel C; Copin MC; Hazzan M; Labalette M; Susen S; Lelievre G; Dessaint JP
    Transplantation; 2000 Mar; 69(6):1102-7. PubMed ID: 10762214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response modulation by pentoxifylline in vitro.
    Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
    Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes : a potential treatment for aseptic loosening of total joint components.
    Pollice PF; Rosier RN; Looney RJ; Puzas JE; Schwarz EM; O'Keefe RJ
    J Bone Joint Surg Am; 2001 Jul; 83(7):1057-61. PubMed ID: 11451976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline inhibits tumor necrosis factor-alpha (TNF alpha)-induced T-lymphoma cell adhesion to endothelioma cells.
    Weiss JM; Vanscheidt W; Pilarski KA; Weyl A; Peschen M; Schöpf E; Vestweber D; Simon JC
    J Invest Dermatol; 1995 May; 104(5):824-8. PubMed ID: 7738362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline.
    Samlaska CP; Winfield EA
    J Am Acad Dermatol; 1994 Apr; 30(4):603-21. PubMed ID: 8157787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pentoxifylline on perforin expression in human PBMC.
    Lazarczyk M; Grzela T; Niderla J; Dziunycz P; Milewski L; Lazarczyk MA; Samaha R
    Int J Mol Med; 2004 Oct; 14(4):725-8. PubMed ID: 15375608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline inhibits perforin-dependent natural cytotoxicity in vitro.
    Lazarczyk M; Grzela T; Korczak-Kowalska G; Niderla J; Oldak M; Jozwiak J; Skopinski P
    Oncol Rep; 2002; 9(2):423-6. PubMed ID: 11836620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
    Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of acute phase gene expression by brain irradiation.
    Hong JH; Chiang CS; Campbell IL; Sun JR; Withers HR; McBride WH
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):619-26. PubMed ID: 7558951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
    Bahrmann P; Hengst UM; Richartz BM; Figulla HR
    Eur J Heart Fail; 2004 Mar; 6(2):195-201. PubMed ID: 14984727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.